March 23, 2023 Comments Off on New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Posted in: Uncategorized
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug ANORO…
March 21, 2023 Comments Off on Drug Patent Expirations for the Week of March 19, 2023 Posted in: Uncategorized
INBRIJA (levodopa) Acorda Patent: 9,155,699 Expiration: Mar 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent …